All residents in Canada who have taken and/or purchased the drug DARVON-N (dextropropoxyphene) their successors, assigns, family members, and dependants are encouraged to sign up for this class action in order to receive compensation.
Only those persons that join the class action and provide their contact information will be eligible for benefits.
Only those persons that join the class action and provide their contact information will be eligible for benefits.
